Second, Z160 is locked and loaded, but how did NMED160 get past the animal models the first time with such low bioavailability? Obviously the animal models liked NMED 160 the first time and Merck liked NMED 160 because of it.
Head to head, Z160 and NMED 160 in animals comparable or not? If so, is bioavailability the only problem here? Overall, I am all systems go for Z160 and the knock on the door says so.